Lorraine1; Albon, Robert F Kushner2; Melanie Davies3; John E Deanfield4; W Timothy Garvey5; Ole Kleist Jeppesen6; Usman Khalid6; Mikhail Kosiborod7; Peter Norkjaer Laursen6; Domenica M Rubino8; Subodh Verma9
N Arabi, A Efthymiadis, A Lumb, G Tan
Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK
The Young Diabetologist and Endocrinologist Forum committee are very pleased to be able to announce the Marjorie Prize. A little known hero in the discovery of insulin was Marjorie the dog who was the first animal to ever be injected with the drug that has transformed and saved so many lives since it’s discovery 100 years ago!
In order to join the registry, you need to agree that the registry organisers are allowed to see all the details above about you and your site/centre. The registry organisers will be analysing only anonymised patient data, but they are not prepared to receive data from anonymised contributors. Please tick the boxes to agree to this and that we may contact you at any time about anything to do with this registry and to invite you to join future audits that might be applicable to you.
Agenda and papers for DTn Strategy Meeting on 10th December 2021
We are contacting you on behalf of the Joint British Diabetes Societies (JBDS) for inpatient care group. We are currently undertaking a review of our guideline "Glycaemic management during enteral feeding in stroke" and as part of this are reaching out to secondary care providers for help. While there is some evidence available, we would like to scope what current national practice is when providing glycaemic support for patient with diabetes or hyperglycaemia, regardless of reason for admission, during enteral feeding.
ABCD is keen to ensure that all our members are aware of the withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes .
Apologies if you've had this update from multiple sources.
We are currently collating feedback on this decision from experts in this area, to share with ABCD members to ensure that people with Type 1 diabetes get the best care and can make informed decisions.
JBDS is updating the ‘Variable rate intravenous insulin infusion (VRIII) for medical inpatients with diabetes’ guideline and we need your help.
We need to collect evidence and are asking UK diabetes teams to let us know what they are currently doing by completing online forms. This can be done either by downloading the form from https://forms.office.com/r/BTM64H2qMj or by scanning the attached QR code.
We are looking to get information on 5 people on a VRIII from each hospital
